Saffron Improved Depression And Reduced Homocysteine Level In Patients With Major Depression: A Randomized, Double-blind Study
Notes for this study:
||µmol/l Mean and SEM. Placebo: before 10.71 after 10.25 (SEM not reported but can be seen in fig 3). Saffron: before 9.31±0.9, after 7.53±0.6.
|Number of Subjects
||18-29, 30-44, 45-64
In a randomized, double-blind, placebo-controlled trial, 40 participants with severe depression took 30 mg of saffron or placebo daily for 4 weeks, both taking 20 mg/day of fluoxetine daily.
There was a greater reduction in homocysteine in the saffron group and while there was also a greater reduction in depression score, the difference wasn't statistically significant.
The trial was registered at: IRCT2013110915334N1